期 |
栏目 |
标题 |
文件 |
卷 78, 编号 4 (2003) |
Editorial |
Erosive duodenojejunitis and enterogenic sepsis as a complication of celiac disease |
|
卷 79, 编号 4 (2004) |
Editorial |
Efficacy of the Rome criteria II in diagnosis of irritable bowel syndrome |
|
卷 81, 编号 2 (2009) |
Editorial |
Postinfection irritable bowel syndrome |
|
卷 82, 编号 2 (2010) |
Editorial |
USE of allogeneic mesenchymal stem cells in the treatment of intestinal inflammatory diseases |
|
卷 83, 编号 12 (2011) |
Editorial |
Postgastroresectional syndromes in therapeutic practice |
|
卷 84, 编号 2 (2012) |
Editorial |
Clinicopathogenetic variants of anemia in patients with intestinal inflammation |
|
卷 84, 编号 2 (2012) |
Editorial |
Pulmonary lesion in a female patient with hormone-dependent ulcerative colitis |
|
卷 84, 编号 8 (2012) |
Editorial |
Optimization of cell therapy in patients with inflammatory bowel diseases |
|
卷 84, 编号 12 (2012) |
Editorial |
Complete elimination of cytomegalovirus without antiviral therapy after systemic mesenchymal stromal cell transplantation in a patient with ulcerative colitis (a clinical case) |
|
卷 85, 编号 2 (2013) |
Editorial |
The role of the small bowel microflora in the development of secondary lactase deficiency and the possibilities of its treatment with probiotics |
|
卷 85, 编号 2 (2013) |
Editorial |
Gluten-sensitivity celiac disease associated with recurrent aphthous stomatitis and schizophrenia |
|
卷 85, 编号 2 (2013) |
Editorial |
New possibilities for overcoming the secondary inefficiency of anti-cytokine therapy in patients with inflammatory bowel diseases |
|
卷 85, 编号 12 (2013) |
Editorial |
Immune response to biological therapy for inflammatory bowel diseases |
|
卷 86, 编号 2 (2014) |
Editorial |
Value of adhesion molecules for evaluating the efficiency of therapy for ulcerative colitis and Crohn's disease |
|
卷 86, 编号 2 (2014) |
Editorial |
Combination biological therapy for fistular Crohn's disease: Clinical demonstration |
|
卷 86, 编号 8 (2014) |
Editorial |
Clinical efficacy of functional foods in patients with gastrointestinal disorders |
|
卷 87, 编号 2 (2015) |
Editorial |
Small intestinal bacterial overgrowth as a cause of lactase deficiency |
|
卷 87, 编号 2 (2015) |
Editorial |
Safety of mesenchymal stromal cell therapy for inflammatory bowel diseases: Results of a 5-year follow-up |
|
卷 88, 编号 2 (2016) |
Editorial |
Irritable bowel syndrome in the light of Rome consensus III (2006): 10 years later |
(Rus)
|
卷 88, 编号 8 (2016) |
Editorial |
Long-term infliximab therapy for ulcerative colitis in real clinical practice |
(Rus)
|
卷 89, 编号 2 (2017) |
Editorial |
Efficacy of adalimumab for Crohn’s disease in real clinical practice |
(Rus)
|